Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 5 (RN7SKP5) is a pseudogene related to the functional 7SK small nuclear RNA (RN7SK), which is a highly conserved non-coding RNA involved in the regulation of transcription elongation by sequestering and controlling the activity of the positive transcription elongation factor b (P-TEFb)[2][3]. However, as a pseudogene, RN7SKP5 does not encode a functional RNA or protein product and has no established biological activity or therapeutic relevance. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations, truncations, or other disabling features. Context and caution: - The functional molecule is RN7SK, not RN7SKP5. Most research and biological functions described in the literature pertain to RN7SK itself, not its pseudogenes like RN7SKP5[2][3][1]. - RN7SKP5 is not considered a therapeutic target, receptor, enzyme, or molecular effector, and has no described role as a biomarker or in disease pathology. - If your use case involves biological functions, disease relevance, or potential as a drug target, refer to RN7SK and not RN7SKP5. Summary of issue: - RN7SKP5 is a pseudogene and not a functional target. If your intent was to inquire about the functional small nuclear RNA, please refer to "RN7SK" (also referred to as "7SK RNA"[2][1][3]). If you require information about the actual functional RNA (RN7SK), please clarify, as it is distinct from RN7SKP5 and is involved in important nuclear regulatory processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 5 (RN7SKP5).